Your browser doesn't support javascript.
loading
Contemporary conditional cancer-specific survival rates in surgically treated adrenocortical carcinoma patients: A stage-specific analysis.
Panunzio, Andrea; Barletta, Francesco; Tappero, Stefano; Cano Garcia, Cristina; Piccinelli, Mattia; Incesu, Reha-Baris; Law, Kyle W; Tian, Zhe; Tafuri, Alessandro; Tilki, Derya; De Cobelli, Ottavio; Chun, Felix K H; Terrone, Carlo; Briganti, Alberto; Saad, Fred; Shariat, Shahrokh F; Bourdeau, Isabelle; Cerruto, Maria A; Antonelli, Alessandro; Karakiewicz, Pierre I.
Afiliação
  • Panunzio A; Department of Urology, Azienda Ospedaliera Universitaria Integrata di Verona, University of Verona, Verona, Italy.
  • Barletta F; Division of Urology, Cancer Prognostics and Health Outcomes Unit, University of Montréal Health Center, Montréal, Québec, Canada.
  • Tappero S; Division of Urology, Cancer Prognostics and Health Outcomes Unit, University of Montréal Health Center, Montréal, Québec, Canada.
  • Cano Garcia C; Department of Urology and Division of Experimental Oncology, URI, Urological Research Institute, IRCCS San Raffaele Scientific Institute, Milan, Italy.
  • Piccinelli M; Division of Urology, Cancer Prognostics and Health Outcomes Unit, University of Montréal Health Center, Montréal, Québec, Canada.
  • Incesu RB; Department of Surgical and Diagnostic Integrated Sciences (DISC), University of Genova, Genova, Italy.
  • Law KW; Department of Urology, IRCCS Policlinico San Martino, Genova, Italy.
  • Tian Z; Division of Urology, Cancer Prognostics and Health Outcomes Unit, University of Montréal Health Center, Montréal, Québec, Canada.
  • Tafuri A; Department of Urology, University Hospital Frankfurt, Frankfurt am Main, Germany.
  • Tilki D; Division of Urology, Cancer Prognostics and Health Outcomes Unit, University of Montréal Health Center, Montréal, Québec, Canada.
  • De Cobelli O; Department of Urology, IEO European Institute of Oncology, IRCCS, Milan, Italy.
  • Chun FKH; Division of Urology, Cancer Prognostics and Health Outcomes Unit, University of Montréal Health Center, Montréal, Québec, Canada.
  • Terrone C; Martini-Klinik Prostate Cancer Center, University Hospital Hamburg-Eppendorf, Hamburg, Germany.
  • Briganti A; Division of Urology, Cancer Prognostics and Health Outcomes Unit, University of Montréal Health Center, Montréal, Québec, Canada.
  • Saad F; Division of Urology, Cancer Prognostics and Health Outcomes Unit, University of Montréal Health Center, Montréal, Québec, Canada.
  • Shariat SF; Department of Urology, Azienda Ospedaliera Universitaria Integrata di Verona, University of Verona, Verona, Italy.
  • Bourdeau I; Martini-Klinik Prostate Cancer Center, University Hospital Hamburg-Eppendorf, Hamburg, Germany.
  • Cerruto MA; Department of Urology, University Hospital Hamburg-Eppendorf, Hamburg, Germany.
  • Antonelli A; Department of Urology, Koc University Hospital, Istanbul, Turkey.
  • Karakiewicz PI; Department of Urology, IEO European Institute of Oncology, IRCCS, Milan, Italy.
J Surg Oncol ; 127(4): 560-567, 2023 Mar.
Article em En | MEDLINE | ID: mdl-36434748
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias do Córtex Suprarrenal / Carcinoma Adrenocortical Idioma: En Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias do Córtex Suprarrenal / Carcinoma Adrenocortical Idioma: En Ano de publicação: 2023 Tipo de documento: Article